The prevalence of CNVs in established BC/OC predisposition genes is poorly studied, and current data are either limited to BRCA1/2 [16,17,18,19] only or based on small study samples for some non-BRCA1/2 cancer predisposition genes [2,20,21]. The gene discussed is BRCA1; the disease is cancer.